Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue).
Journal: Cancer cytopathology
Published: February 25, 2026
Analytical validation of Aspyre Clinical Test for Lung (Blood): A multiplexed PCR and pyrophosphorolysis-based assay for detecting actionable NSCLC variants in plasma cfDNA and cfRNA.
Journal: The journal of liquid biopsy
Published: April 03, 2025
Aspyre Lung enables robust variant calling in samples that fail next generation sequencing quality control.
Journal: Translational oncology
Published: March 24, 2025
Evaluation of the ASPYRE-Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites.
Journal: Translational lung cancer research
Published: June 28, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Journal: The oncologist
Published: September 18, 2023
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology.
Journal: Science translational medicine
Published: February 05, 2016
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study.
Journal: The Lancet. Haematology
Published: March 06, 2015
A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 13, 2014
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors.
Journal: Cancer
Published: September 04, 2014
Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers.
Journal: Cancer chemotherapy and pharmacology
Published: December 12, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 26, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026